Neurocrine Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 12.83 M | $1.82 B | 0.98% | 12.90% |
| VANGUARD GROUP INC | 01/29/2026 | 9.70 M | $1.38 B | -0.06% | 9.75% |
| DODGE & COX | 02/13/2026 | 5.51 M | $781.21 M | -0.87% | 5.54% |
| JPMORGAN CHASE & CO | 02/11/2026 | 5.20 M | $737.57 M | 9.94% | 5.23% |
| STATE STREET CORP | 02/13/2026 | 4.24 M | $601.74 M | -2.39% | 4.26% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 3.27 M | $462.65 M | 17.96% | 3.29% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.24 M | $317.53 M | -7.42% | 2.25% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.06 M | $291.34 M | 1.70% | 2.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.87 M | $265.54 M | -34.69% | 1.88% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 1.74 M | $247.43 M | -3.71% | 1.75% |
| BELLEVUE GROUP AG | 02/17/2026 | 1.70 M | $241.58 M | -3.39% | 1.71% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/13/2026 | 1.40 M | $197.99 M | 47.24% | 1.40% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 1.29 M | $178.25 M | 7.36% | 1.30% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.22 M | $173.20 M | 31.92% | 1.23% |
| MORGAN STANLEY | 02/13/2026 | 1.21 M | $171.53 M | -33.80% | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 1.18 M | $167.98 M | 0.00% | 1.19% |
| NORGES BANK | 02/10/2026 | 1.15 M | $162.66 M | 100.00% | 1.15% |
| RTW INVESTMENTS, LP | 02/17/2026 | 1.06 M | $150.63 M | 0.00% | 1.07% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 984.81 K | $139.68 M | 183.35% | 0.99% |
| UBS GROUP AG | 01/29/2026 | 983.53 K | $139.49 M | 169.78% | 0.99% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 850.63 K | $120.65 M | 2.54% | 0.85% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 842.59 K | $119.50 M | 466.36% | 0.85% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 820.24 K | $116.33 M | 17.68% | 0.82% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 776.93 K | $110.30 M | 12.04% | 0.78% |
| BRAIDWELL LP | 02/17/2026 | 751.53 K | $106.59 M | -14.63% | 0.76% |
| IEQ CAPITAL, LLC | 02/13/2026 | 745.11 K | $105.68 M | 7.58% | 0.75% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 738.68 K | $104.77 M | -2.98% | 0.74% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 722.48 K | $102.47 M | -5.59% | 0.73% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 716.48 K | $101.61 M | 0.89% | 0.72% |
| FIERA CAPITAL CORP | 02/11/2026 | 637.41 K | $90.40 M | 32.88% | 0.64% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 631.42 K | $89.22 M | 11.37% | 0.63% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 585.68 K | $83.07 M | -4.70% | 0.59% |
| SWEDBANK AB | 02/09/2026 | 584.13 K | $82.85 M | 6.72% | 0.59% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/11/2026 | 576.65 K | $81.79 M | -2.98% | 0.58% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 555.49 K | $78.79 M | -10.13% | 0.56% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 532.76 K | $75.56 M | -16.10% | 0.54% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 528.10 K | $74.90 M | -25.01% | 0.53% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/11/2026 | 507.74 K | $72.01 M | -0.88% | 0.51% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 02/17/2026 | 507.17 K | $39.86 M | 161.50% | 0.51% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 486.81 K | $69.04 M | 34.07% | 0.49% |
| ZURICH INSURANCE GROUP LTD/FI | 02/17/2026 | 459.44 K | $65.16 M | 100.00% | 0.46% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 459.18 K | $65.13 M | -22.85% | 0.46% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 442.87 K | $62.81 M | -54.68% | 0.45% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 389.30 K | $55.21 M | -22.37% | 0.39% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 367.94 K | $52.19 M | -18.38% | 0.37% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 364.53 K | $51.70 M | -40.20% | 0.37% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 02/13/2026 | 360.71 K | $51.16 M | -12.38% | 0.36% |
| MARSHALL WACE, LLP | 02/13/2026 | 348.84 K | $49.48 M | 258.56% | 0.35% |
| INVESCO LTD. | 02/19/2026 | 343.42 K | $48.71 M | 6.12% | 0.35% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/15/2026 | 339.43 K | $47.72 M | -11.25% | 0.34% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 849 institutional investors and hedge funds held shares of Neurocrine Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 12.83 M
VANGUARD GROUP INC: 9.7 M
DODGE & COX: 5.51 M
JPMORGAN CHASE & CO: 5.2 M
STATE STREET CORP: 4.24 M
AQR CAPITAL MANAGEMENT LLC: 3.27 M
99.48% of Neurocrine Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 121.99 M shares in the last 24 months. This purchase volume represents approximately $15.69 B in transactions.